Ad is loading...
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
TENWX
Price
$11.19
Change
-$0.04 (-0.36%)
Updated
Nov 15 closing price
Ad is loading...

RNWFX vs TENWX

Header iconRNWFX vs TENWX Comparison
Open Charts RNWFX vs TENWXBanner chart's image
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
Nuveen Emerging Markets Eq Idx W
Price$11.19
Change-$0.04 (-0.36%)
VolumeN/A
CapitalizationN/A
RNWFX vs TENWX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RNWFX vs. TENWX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNWFX is a Hold and TENWX is a Sell.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. TENWX (6.91B). TENWX pays higher dividends than RNWFX: TENWX (3.16) vs RNWFX (1.51). RNWFX was incepted earlier than TENWX: RNWFX (23 years) vs TENWX (6 years). RNWFX is a more actively managed with annual turnover of: 32.00 vs. TENWX (7.00). TENWX has a lower initial minimum investment than RNWFX: TENWX (0) vs RNWFX (250). TENWX annual gain was more profitable for investors over the last year : 12.54 vs. RNWFX (11.54). RNWFX return over 5 years is better than : 17.17 vs. TENWX (13.05).
RNWFXTENWXRNWFX / TENWX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years6 years-
Gain YTD7.0997.59693%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets60.9B6.91B881%
Annual Yield % from dividends1.513.1648%
Returns for 1 year11.5412.5492%
Returns for 3 years-14.55-11.18130%
Returns for 5 years17.1713.05132%
Returns for 10 years41.00N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics